We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

National Pharmaceuticals' Lead Therapeutic Drug, GLB333 Receives Financial Grant

News   Apr 20, 2011

 
National Pharmaceuticals' Lead Therapeutic Drug, GLB333 Receives Financial Grant
 
 
Advertisement
 

RELATED ARTICLES

Gene Therapy Beats the Blood-Brain Barrier To Cure Cat Disease

News

In a new study, successfully applied a gene therapy platform to cross the blood-brain barrier and completely correct brain defects in a cat model of a human genetic disease.

READ MORE

Managing Immune Helper Cells in Elderly Could Improve Vaccine Efficacy

News

Scientists have taken a deeper look at how the immune system changes with age and their findings could help to make flu vaccines much more protective.

READ MORE

mRNA-1273 COVID-19 Vaccine Protects Airway in Nonhuman Primate Study

News

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE